Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Respiri Limited ( (AU:RSH) ) has shared an update.
Respiri Limited announced the successful completion of its general meeting of shareholders, where all proposed resolutions were passed. This development signifies a positive step in the company’s governance and could have implications for its strategic direction and stakeholder relations, reinforcing its commitment to advancing respiratory health management technologies.
More about Respiri Limited
Respiri Limited is an e-Health SaaS company that specializes in respiratory health management and Remote Patient Monitoring services. The company has developed the wheezo® technology, a smart device that helps improve asthma management by detecting wheeze, a common symptom of asthma and other respiratory diseases. It operates in Melbourne, Australia, and New York, USA, aiming to improve the quality of life for individuals with respiratory conditions.
YTD Price Performance: 4.00%
Average Trading Volume: 253,500
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $68.45M
For detailed information about RSH stock, go to TipRanks’ Stock Analysis page.
